Namzaric
Namzaric is a neurology medication containing Donepezil + Memantine, available as 5/5mg tablets.
Details
- Conditions
- Alzheimer's disease
- Therapeutic Class
- Cognitive enhancer
- Pharmacological Class
- Acetylcholinesterase inhibitor, NMDA receptor antagonist
- Minor Side Effects
- nausea, diarrhoea, dizziness
- Moderate Side Effects
- insomnia, anaemia, fatigue
- Dosage Forms
- Capsule
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Onset Time
- 4–6 weeks
- Duration
- long-term
- Storage Instructions
- Store at controlled room temperature.
- Drug Interactions
- anticholinergics, succinylcholine, beta-blockers
- Age Restrictions
- Not for children.